Mustang Bio Inc expected to post a loss of 19 cents a share - Earnings Preview

Mustang Bio

17/03/2023 22:02

* Mustang Bio Inc  MBIO.OQ   MBIO.O  is expected to show no
change
in quarterly revenue when it reports  results on March 21
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Mustang Bio Inc is
for a
loss of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Mustang Bio
Inc
is $5​, above​ its last closing price of $0.36. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.20       -0.20      -0.18     Beat    8.9
 Jun. 30 2022  -0.21       -0.21      -0.19     Beat    8.7
 Mar. 31 2022  -0.18       -0.18      -0.20     Missed  -8.7​
 Dec. 31 2021              -0.19      -0.22     Missed  -14.6
 ​​Sep.        -0.18       -0.18      -0.19     Missed  -6.7
 30 2021                                                
 Jun. 30 2021  -0.20       -0.20      -0.16     Beat    19​
 Mar. 31 2021  -0.19       -0.19      -0.19     Met     2.6
 Dec. 31 2020  -0.20       -0.21      -0.32     Missed  -54.2
 This summary was machine generated March 17 at 22:02 GMT.  All
figures in US dollars  unless otherwise stated